Literature DB >> 20192239

Antiangiogenic metabolites from a marine-derived fungus, Hypocrea vinosa.

Yuu Ohkawa1, Kazuhiko Miki, Toshihiro Suzuki, Kazuto Nishio, Takashi Sugita, Kaoru Kinoshita, Kunio Takahashi, Kiyotaka Koyama.   

Abstract

The aims of this study were to investigate the role of tyrosine kinase in intracellular signaling and to search for lead compounds with tyrosine kinase inhibitory activity from metabolites of marine-derived fungi. We initially prepared 400 extracts from 200 species of marine fungi and then subjected them to a tyrosine kinase screening assay using human umbilical vein endothelial cell lysate. Tyrosine kinase inhibitory activity was observed among certain metabolites of Hypocrea vinosa. We isolated one known compound, SC2051 (1), as well as two new compounds, hypochromins A (2) and B (3), which have a bis(naphtho-gamma-pyrone) skeleton. Compounds 1-3 showed tyrosine kinase inhibitory activity, with IC(50) values of 42.1, 58.7, and 18.0 microMu, respectively. Furthermore, compounds 1-3 exhibited inhibitory effects on proliferation, migration, and tubule formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192239     DOI: 10.1021/np900698p

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  9 in total

1.  A novel nucleoside from the edible mushroom, Tricholoma japonicum.

Authors:  Akane Haraguchi; Kaoru Kinoshita; Miyuki Fukai; Kiyotaka Koyama
Journal:  J Nat Med       Date:  2015-05-15       Impact factor: 2.343

2.  Anti-angiogenic effect of α-mangostin.

Authors:  Tomoko Shiozaki; Miyuki Fukai; Elvira Hermawati; Lia Dewi Juliawaty; Yana Maolana Syah; Euis Holisotan Hakim; Ploenthip Puthongking; Toshihiro Suzuki; Kaoru Kinoshita; Kunio Takahashi; Kiyotaka Koyama
Journal:  J Nat Med       Date:  2012-03-02       Impact factor: 2.343

Review 3.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

4.  Pigmentosins from Gibellula sp. as antibiofilm agents and a new glycosylated asperfuran from Cordyceps javanica.

Authors:  Soleiman E Helaly; Wilawan Kuephadungphan; Patima Phainuphong; Mahmoud A A Ibrahim; Kanoksri Tasanathai; Suchada Mongkolsamrit; Janet Jennifer Luangsa-Ard; Souwalak Phongpaichit; Vatcharin Rukachaisirikul; Marc Stadler
Journal:  Beilstein J Org Chem       Date:  2019-12-16       Impact factor: 2.883

Review 5.  Metabolic Potential of Halophilic Filamentous Fungi-Current Perspective.

Authors:  Weronika Śliżewska; Katarzyna Struszczyk-Świta; Olga Marchut-Mikołajczyk
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

6.  New Furan and Cyclopentenone Derivatives from the Sponge-Associated Fungus Hypocrea Koningii PF04.

Authors:  Li-Jian Ding; Bin-Bin Gu; Wei-Hua Jiao; Wei Yuan; Ying-Xin Li; Wei-Zhuo Tang; Hao-Bing Yu; Xiao-Jian Liao; Bing-Nan Han; Zhi-Yong Li; Shi-Hai Xu; Hou-Wen Lin
Journal:  Mar Drugs       Date:  2015-08-26       Impact factor: 5.118

Review 7.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

8.  Unusual dimeric tetrahydroxanthone derivatives from Aspergillus lentulus and the determination of their axial chiralities.

Authors:  Tian-Xiao Li; Ming-Hua Yang; Ying Wang; Xiao-Bing Wang; Jun Luo; Jian-Guang Luo; Ling-Yi Kong
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

9.  Hybrid Polyketides from a Hydractinia-Associated Cladosporium sphaerospermum SW67 and Their Putative Biosynthetic Origin.

Authors:  Seoung Rak Lee; Dahae Lee; Hee Jeong Eom; Maja Rischer; Yoon-Joo Ko; Ki Sung Kang; Chung Sub Kim; Christine Beemelmanns; Ki Hyun Kim
Journal:  Mar Drugs       Date:  2019-10-24       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.